N-(2-(7-Bromo-5-oxo-9-pentyl-8,9-dihydro-5H-[1,2,4]triazolo[4,3-a]purin-3-yl)ethyl)-2-methylisonicotinamide

Catalog No. :
ACZWIO549
CAS No. :
1000166-63-1
Molecular Formula :
C20H23BrN8O2
Molecular Weight :
487.36

IUPAC Name:N-(2-(7-bromo-5-oxo-9-pentyl-6,9-dihydro-5H-[1,2,4]triazolo[4,3-a]purin-3-yl)ethyl)-2-methylisonicotinamide

N-(2-(7-Bromo-5-oxo-9-pentyl-8,9-dihydro-5H-[1,2,4]triazolo[4,3-a]purin-3-yl)ethyl)-2-methylisonicotinamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(2-(7-Bromo-5-oxo-9-pentyl-8,9-dihydro-5H-[1,2,4]triazolo[4,3-a]purin-3-yl)ethyl)-2-methylisonicotinamide
IUPAC NameN-(2-(7-bromo-5-oxo-9-pentyl-6,9-dihydro-5H-[1,2,4]triazolo[4,3-a]purin-3-yl)ethyl)-2-methylisonicotinamide
Molecular FormulaC20H23BrN8O2
Molecular Weight487.36
SMILESO=C(C1=CC(C)=NC=C1)NCCC2=NN=C(N32)N(CCCCC)C4=C(N=C(Br)N4)C3=O
InChI KeyDVTXVXBFUKVHBK-UHFFFAOYSA-N
SynonymN-[2-(7-BROMO-5-OXO-9-PENTYL-6,9-DIHYDRO-5H-[1,2,4]TRIAZOLO[4,3-A]PURIN-3-YL)-ETHYL]-2-METHYL-ISONICOTINAMIDE;4-Pyridinecarboxamide, N-[2-(7-bromo-8,9-dihydro-5-oxo-9-pentyl-5H-1,2,4-triazolo[4,3-a]purin-3-yl)ethyl]-2-methyl-
CAS No.1000166-63-1

Synthetic Route by SureRoute

1. ACZWIO549 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACKGDE150 route compound structure diagram
    ACKGDE1504021-11-8 In Stock
  4. Then
  5. ACZWIO549 route product structure diagram
    ACZWIO5491000166-63-1
Inquiry

2. ACZWIO549 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACZWIO549 route product structure diagram
    ACZWIO5491000166-63-1
Inquiry

Comments (0)